4D Molecular Therapeutics Inc.
13F holders, Q2 2026 (June 30)1holders
1new positions
0sold out
$13.30avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding 4D Molecular Therapeutics Inc. in their 13F filings, unchanged from Q4 2025. 1 opened new positions and 0 sold out. The largest holder was Allworth Financial LP ($6K).
- Company
- 4D Molecular Therapeutics Inc.
- CUSIP
- 00351E104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $6K |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q2 2026: 417 shares bought, net +417 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Allworth Financial LP | 0.00% | New | 417 | $6K |
"% of holder's portfolio" is 4D MOLECULAR THERAPEUTICS IN's weight in each manager's 13F, not the share of 4D Molecular Therapeutics Inc. the manager owns.